Device big five join to undercut e-health charges
This article was originally published in Clinica
Five of the world's largest device and diagnostic companies are to form an independent internet "trading exchange" which will provide competition to the growing number of dot.com healthcare companies springing up to sell over the internet.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.